Progression to treatment failure among Chinese patients with type 2 diabetes initiated on metformin versus sulphonylurea monotherapy—The Hong Kong Diabetes Registry-Reference-Cited by-同舟云学术

Progression to treatment failure among Chinese patients with type 2 diabetes initiated on metformin versus sulphonylurea monotherapy—The Hong Kong Diabetes Registry

Published:2016-02 Issue: Volume:112 Page:57-64
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Jiang Guozhi,Luk Andrea O.,Yang Xilin,Wang Ying,Tam Claudia H.T.,Lau Siu Him,Ozaki Risa,Kong Alice P.S.,Tong Peter C.,Chow Chun Chung,Chan Juliana C.N.,So Wing Yee,Ma Ronald C.W.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference28 articles.

1. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes;Group;N Engl J Med,2008

2. AACE comprehensive diabetes management algorithm 2013;Garber;Endocr Pract,2013

3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS, 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

4. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy;Kahn;N Engl J Med,2006

5. Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus;Eurich;Pharmacotherapy,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real world evidence of clinical predictors of glycaemic response to glucose‐lowering drugs among Chinese with type 2 diabetes;Diabetes/Metabolism Research and Reviews;2023-02-02

2. CYP2C19 Loss‐of‐function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 Diabetes;Clinical Pharmacology & Therapeutics;2021-10-30

3. Early combination therapy delayed treatment escalation in newly diagnosed young‐onset type 2 diabetes: A subanalysis of the VERIFY study;Diabetes, Obesity and Metabolism;2020-09-29

4. Precision medicine in diabetes prevention, classification and management;Journal of Diabetes Investigation;2018-04-25

5. Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study;Journal of Diabetes & Metabolic Disorders;2015-12